Neutralizing antibody response variation against dengue 3 strains

Area of Science:

• Virology
• Immunology
• Epidemiology

Background:

• Dengue virus type 3 (DENV-3) outbreaks in Havana provided a unique opportunity to study homotypic virus neutralization.
• Understanding antibody responses to different DENV-3 genotypes and epidemic strains is crucial for disease control.

Purpose of the Study:

• To evaluate the neutralizing antibody activity in human sera against seven DENV-3 strains.
• To investigate differences in antibody neutralization based on DENV-3 genotype and epidemic evolution.

Main Methods:

• Analysis of 20 late convalescent sera from Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) patients infected during the 2001-2002 Havana DENV-3 epidemic.
• Plaque reduction neutralization technique (PRNT) was used to determine serum neutralizing antibody titers against seven DENV-3 strains, including two genotypes and strains from different time points.

Main Results:

• Sera exhibited higher neutralizing antibody titers against DENV-3 genotype III strains compared to genotype V.
• Significantly higher neutralizing antibody levels were detected against a DENV-3 strain isolated towards the end of the 2001-2002 epidemic.
• A trend of increasing geometric mean titers (GMT) of neutralizing antibodies was observed correlating with epidemic progression.
• Individuals with DF generally showed higher antibody levels than those with DHF.

Conclusions:

• Significant differences in neutralization capacity were observed, indicating potential viral evolution within the DENV-3 epidemic.
• These findings highlight the importance of considering viral genetic diversity and temporal changes in DENV-3 strains for effective dengue pathogenesis understanding and vaccine design.